Inventor · disambiguated record
Shi Du Yan
Also filed as: YAN SHI D · YAN SHI DU
13 granted patents·12 pending applications·348 citations·filing 1997–2016
93Inventor score
Top patents by PatentIndex Score
25 records- 0195US6825164B1Method to increase cerebral blood flow in amyloid angiopathyUNIV COLUMBIA·Filed 2000·Granted Nov 30, 2004·75 cites·9 claims
- 0294US6677299B2Method to increase cerebral blood flow in amyloid angiopathyTRUSTEE OF COLUMBIA UNIVERSITY·Filed 2001·Granted Jan 13, 2004·68 cites·16 claims
- 0392US7258857B2Rage-related methods for treating inflammationUNIV COLUMBIA·Filed 2001·Granted Aug 21, 2007·42 cites·11 claims
- 0492US6563015B1Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereofUNIV COLUMBIA·Filed 2000·Granted May 13, 2003·31 cites·4 claims
- 0585US6555651B2Ligand binding site of rage and uses thereofUNIV COLUMBIA·Filed 1997·Granted Apr 29, 2003·65 cites·4 claims
- 0681US8124829B2Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereofSTERN DAVID M·Filed 2010·Granted Feb 28, 2012·3 cites·2 claims
- 0781US6268479B1Intracellular amyloid-beta peptide binding (ERAB) polypeptideUNIV COLUMBIA·Filed 1997·Granted Jul 31, 2001·32 cites·2 claims
- 0880US7919670B1Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereofUNIV COLUMBIA·Filed 2000·Granted Apr 5, 2011·4 cites·2 claims
- 0974US6891081B1Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereofUNIV COLUMBIA·Filed 2000·Granted May 10, 2005·14 cites·8 claims
- 1065US2008214453A1Methods for treating inflammationUNIV COLUMBIA·Filed 2007·Application pending·0 cites
- 1164US6994974B1Intracellular amyloid-beta binding (ERAB) polypeptide-related assaysUNIV COLUMBIA·Filed 1999·Granted Feb 7, 2006·12 cites·5 claims
- 1259US9296824B2Methods for treating and preventing multiple sclerosisYAN SHI DU·Filed 2008·Granted Mar 29, 2016·0 cites·4 claims
- 1358US7060870B1Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer's disease and uses thereofUNIV COLUMBIA·Filed 2000·Granted Jun 13, 2006·2 cites·4 claims
- 1458US2008274975A1Methods and Compositions for Inhibiting Abad/Abeta Protein InteractionUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 1557US2009028882A1Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereofUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 1656US2007167360A1Methods for treating multiple sclerosisYAN SHI D·Filed 2004·Application pending·0 cites
- 1755US2008019986A1Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereofUNIV COLUMBIA·Filed 2007·Application pending·0 cites
- 1854US2008260717A1Methods for Reducing Seizure-Induced Neuronal DamageUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 1954US2012291145A1Transgenic mice over-expressing receptor for advanced glycation endproduct (rage) in brain and uses thereofSTERN DAVID M·Filed 2012·Application pending·0 cites
- 2054US2005170382A1RAGE-related compositionsUNIV COLUMBIA·Filed 2004·Application pending·0 cites
- 2151US2009060925A1Rage Fusion Proteins and Methods of UseUNIV COLUMBIA·Filed 2005·Application pending·0 cites
- 2250US8450454B2Compositions for inhibiting ABAD/ABeta protein interactionYAN SHI DU·Filed 2011·Granted May 28, 2013·0 cites·4 claims
- 2346US2010291074A1Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's diseaseUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 2445US2016237168A1Methods for Treating and Preventing Multiple SclerosisYAN SHI DU·Filed 2016·Application pending·0 cites
- 2528US2003037344A1Method for evaluating the ability of a compound to inhibit neurotoxicityFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shi Du Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →